Study Links Beginning Cannabis Use to Cope with Stress or Trauma to Higher Paranoia and Mental Health Burden

Two new studies have raised concerns that using cannabis to cope with stress, pain or past trauma may be associated with greater later paranoia and mental health symptoms, researchers reported.

One of the studies, published in BMJ Mental Health, analyzed responses from more than 3,000 adults who currently use or previously used cannabis. Participants who first tried cannabis as a way to manage pain, stress or depression were more likely to report elevated paranoia and anxiety later in life than those whose initial use was motivated by curiosity or social reasons.

The study also collected self-reported measures of consumption. On average, participants reported using amounts equivalent to roughly 10 to 17 joints per week when accounting for contemporary marijuana potency, which researchers and public health experts say is higher than decades past. The American Psychological Association has noted that average tetrahydrocannabinol (THC) concentrations in cannabis have risen since the 1960s and 1970s, when products were typically far weaker.

Researchers contrasted different initial motivations for cannabis use and found the lowest levels of paranoia and anxiety among people who said they first used the drug out of curiosity or for recreation. By comparison, those who cited coping with emotional distress or physical pain as their initial reason for trying cannabis showed higher rates of later paranoia and related mental health struggles.

The studies stop short of proving cause and effect but point to consistent patterns that concern public health officials and clinicians. "This study further spotlights that youth cannabis use can be destructive to developing brains," an expert said, reflecting concerns about the interaction between early use, mental health vulnerabilities and stronger modern cannabis products.

The researchers used survey-based approaches to assess participants’ histories of cannabis use, reasons for first use and current mental health measures. The analysis focused on associations between initial motivations and later reported symptoms rather than on experimentally established mechanisms.

The findings add to a growing body of literature exploring links between cannabis use and mental health outcomes. Public health researchers have previously reported associations between heavy or frequent cannabis use and conditions such as psychosis, anxiety and depression, particularly among younger users and those with preexisting vulnerabilities.

Authors and independent experts said the results underscore the need for further research to clarify how motivations for use, age at initiation and product potency interact to affect mental health. They also urged continued public education about potential risks, particularly as higher-potency products and edible forms of cannabis become more widely available.

The studies reinforce a cautious perspective among some clinicians and researchers that using cannabis as a self-directed way to manage stress or trauma may not relieve, and could be associated with worsening, certain mental health symptoms. Additional longitudinal and experimental research will be needed to better define causal pathways and to inform prevention and treatment guidance.